跳至主要内容
临床试验/CTRI/2016/06/007010
CTRI/2016/06/007010已完成2 期

Pharmaceutical Standardization of Ashtangavaleha prepared by two methods and their comparative clinical efficacy on Tamaka Shwasa (Bronchial asthma)

Institute for Post Graduate Teaching and Research in Ayurveda0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Both the sexes having age between 16 years to 60 years
  • Mild persistent cases of Bronchial Asthma with daytime symptoms 3-6/week and nocturnal symptoms with 3-4/month
  • Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 week

排除标准

  • Known patients of diabetes
  • Dyspnoea resulting from cardiac origin and anaemia
  • Age above 60 years and below 16 years
  • Patients suffering from tuberculosis, malignancy and other chronic debilitating diseases, HIV positive cases
  • Pregnant and lactating mothers
  • Patients who depend on regular use of inhalers
  • Patients suffering with other types of Shwasa, i.e. Maha, Urdha, Chhinna Shwasa

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda

相似试验